Table 1.
Clinical, adiposity and echocardiographic characteristics of the study cohort.
| All (n=843) | |
|---|---|
| Age (years) | 67 ±12 |
| Men (%) | 45 |
| Race (%) | |
| White | 61 |
| Black | 31 |
| Other | 8 |
| Body Mass Index (kg/m2) | 26 ±4 |
| Waist circumference (cm) | 90 ±13 |
| Smoking (ever, %) | 44 |
| Physical activity (≥1000 kcal/week, %) | 59 |
| Diabetes (%) | 20 |
| Hypercholesterolemia (%) | 78 |
| Hypertension (%) | 46 |
| Antihypertensive medications (%) | 45 |
| Systolic Blood Pressure (mmHg) | 120 ±16 |
| Heart Rate (beats/min) | 67 ±11 |
| Medications, ATC code (%) | |
| Diuretics, C03 | 15 |
| Beta Blocking Agents, C07 | 14 |
| Calcium channel blockers, C08 | 10 |
| Renin-angiotensin system, C09 | 28 |
| Lipid modifying, C10 | 47 |
| Triglycerides (TG, mg/dL) | 88 (67–120) |
| Sex hormone_binding globulin (SHBG, nmol/L) | 65 (45–94) |
| Leptin (ng/mL) | 14.3 (6.7–28.4) |
| Adiponectin (μg/mL) | 11.8 (6.5–20.1) |
| Total Body Fat Mass (TBF, kg) | 27 ±10 |
| Fat Percentage (%) | 35 |
| Visceral Adipose Tissue area (VAT, cm²) | 102 ±54 |
| Subcutaneous Adipose Tissue area (SAT, cm²) | 275 ±124 |
| E/A ratio | 0.96 ±0.3 |
| Early diastolic mitral annulus velocity (Em, cm/s) | 9.1 ±2.2 |
| E/Em ratio | 8.3 ±2.4 |
| Em/Am ratio | 0.93 ±0.34 |
| LV mass index (g/m2) | 68 ±22 |
| LV ejection fraction (%) | 69 ±9 |
Values are mean ±SD, median (interquartile ranges) or percentages. ATC= Anatomical Therapeutic Chemical classification. Left ventricular (LV) mass was indexed to body surface area.